Numerous clinical trials are currently underway to assess the efficacy and safety of hydroxychloroquine in cancer treatment. Preliminary results indicate that it can enhance the effectiveness of existing therapies, but more research is needed to confirm these findings across larger and more diverse patient populations. The outcomes of these trials will be crucial in determining whether hydroxychloroquine can become a standard part of cancer treatment protocols.
